Vaxxinity, Inc.
DelistedCIK 1851657fmd_02F47A6486N1JXW5FHM98A309KManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Dec 31, 2023, 14 periods
Latest annual · FY2022
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (58)
- Net income
- (57)
- Free cash flow
- (58)
Latest quarter · Q4 FY2023
Millions- Operating income
- (12)
- Net income
- (11)
- Free cash flow
- (12)
Vaxxinity, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Operating income | -$58.3 million | -$76 million | 10-K 2024-03-27 · proof | |
| Net income | -$56.9 million | -$75.2 million | 10-K 2024-03-27 · proof | |
| Cash from operating activities | -$57.2 million | -$55.9 million | 10-K 2024-03-27 · proof | |
| Free cash flow | -$58 million | -$57.8 million | 10-K 2024-03-27 · proof | |
| Total assets | $44.3 million | $106.4 million | -58.4% | 10-K 2024-03-27 · proof |
| Total liabilities | $30.9 million | $44.2 million | -30.1% | 10-K 2024-03-27 · proof |
| Cash and cash equivalents | $4.9 million | $33.5 million | -85.3% | 10-K 2024-03-27 · proof |
- What was Vaxxinity, Inc.'s operating income in fiscal 2023?
- Vaxxinity, Inc. reported operating income of -$58.3 million for fiscal 2023 (the year ended Dec 31, 2023), against -$76 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Vaxxinity, Inc.'s net income in fiscal 2023?
- Vaxxinity, Inc. reported net income of -$56.9 million for fiscal 2023 (the year ended Dec 31, 2023), against -$75.2 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Vaxxinity, Inc.'s cash from operating activities in fiscal 2023?
- Vaxxinity, Inc. reported cash from operating activities of -$57.2 million for fiscal 2023 (the year ended Dec 31, 2023), against -$55.9 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Vaxxinity, Inc.'s free cash flow in fiscal 2023?
- Vaxxinity, Inc. reported free cash flow of -$58 million for fiscal 2023 (the year ended Dec 31, 2023), against -$57.8 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Vaxxinity, Inc.'s total assets?
- As of Dec 31, 2023, Vaxxinity, Inc. reported total assets of $44.3 million, against $106.4 million a year earlier (-58.4%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Vaxxinity, Inc.'s total liabilities?
- As of Dec 31, 2023, Vaxxinity, Inc. reported total liabilities of $30.9 million, against $44.2 million a year earlier (-30.1%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Vaxxinity, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Vaxxinity, Inc. reported cash and cash equivalents of $4.9 million, against $33.5 million a year earlier (-85.3%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1851657&period_type=annual&limit=5"Information only, not investment advice.